Correction: HIV DNA Reservoir Increases Risk for Cognitive Disorders in cART-Naïve Patients

Correction: HIV DNA Reservoir Increases Risk for Cognitive Disorders in cART-Naïve Patients

Bibliographic Details
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2014-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3880918/?tool=EBI

Similar Items

HIV DNA reservoir increases risk for cognitive disorders in cART-naïve patients.
by: Victor G Valcour, et al.
Published: (2013-01-01)

Remission of HIV-related naïve and high-risk Burkitt’s lymphoma treated by autologous stem cell transplantation plus cART
by: Haiyan Min, et al.
Published: (2018-12-01)

Pre-cART Immune Parameters in People Living With HIV Might Help Predict CD8+ T-Cell Characteristics, Inflammation Levels, and Reservoir Composition After Effective cART
by: Jimena Salido, et al.
Published: (2021-10-01)

Monocytes as Regulators of Inflammation and HIV-Related Comorbidities during cART
by: Joshua J. Anzinger, et al.
Published: (2014-01-01)

HIV-Associated Hodgkin's Lymphoma: Prognosis and Therapy in the Era of cART
by: Caron A. Jacobson, et al.
Published: (2012-01-01)

Lack of Association of Vascular Risk Factors with HIV-Associated Neurocognitive Disorders in cART-Treated Adults Aged ≥ 50 Years in Tanzania
by: Katherine A. Flack, et al.
Published: (2024-05-01)

HLA-C*18:01 and KIR2DL2+C1 genetic variants are associated with low viral load in cART naive HIV-infected adult Zimbabweans
by: Mhandire, K, et al.
Published: (2018)

Comparison of two screening tests for HIV-Associated Neurocognitive Disorder suspected Japanese patients with respect to cART usage.
by: Kaoru Kami-Onaga, et al.
Published: (2018-01-01)

Impact of early cART on HIV blood and semen compartments at the time of primary infection.
by: Antoine Chéret, et al.
Published: (2017-01-01)

Improved induced innate immune response after cART initiation in people with HIV
by: Malene Hove-Skovsgaard, et al.
Published: (2022-08-01)

Expression of CD39 Is Correlated With HIV DNA Levels in Naïve Tregs in Chronically Infected ART Naïve Patients
by: Jin-Wen Song, et al.
Published: (2019-10-01)

DETERMINATION OF INTRACELLULAR REACTIVE OXYGEN SPECIES IN T-CELL SUBSETS OF HIV+ PATIENTS ON CONTINUOUS cART
by: Radoslava Emilova, et al.
Published: (2022-10-01)

Association between cytokine and increased risk of death in ART- naïve and ART-non-adherence patients hospitalized with advanced HIV disease
by: Yury Oliveira Chaves, et al.
Published: (2025-02-01)

Risk Factors for Non-Adherence to cART in Immigrants with HIV Living in the Netherlands: Results from the ROtterdam ADherence (ROAD) Project.
by: Sabrina K Been, et al.
Published: (2016-01-01)

Multimodal Approach to Neurocognitive Function in People Living with HIV in the cART Era: A Comprehensive Review
by: Charalampos D. Moschopoulos, et al.
Published: (2024-04-01)

Plasma Lipidomic Profiles in cART-Treated Adolescents with Perinatally Acquired HIV Compared to Matched Controls
by: Julie van der Post, et al.
Published: (2024-04-01)

Assessing the HIV Care Continuum in Latin America: progress in clinical retention, cART use and viral suppression
by: Peter F Rebeiro, et al.
Published: (2016-01-01)

“cART intensification by the HIV-1 Tat B clade vaccine: progress to phase III efficacy studies”
by: Aurelio Cafaro, et al.
Published: (2018-02-01)

Combination antiretroviral therapy (cART)-induced hippocampal disorders: Highlights on therapeutic potential of Naringenin and Quercetin
by: Edidiong N. Akang, et al.
Published: (2019-06-01)

Classification of Malaria Complication Using CART (Classification and Regression Tree) and Naïve Bayes
by: Rachmadania Irmanita, et al.
Published: (2021-02-01)

Survival in HIV-infected patients after a cancer diagnosis in the cART Era: results of an italian multicenter study.
by: Daria Gotti, et al.
Published: (2014-01-01)

Later cART initiation in migrant men from sub-Saharan Africa without advanced HIV disease in France.
by: Laure-Amélie de Monteynard, et al.
Published: (2015-01-01)

Impact of Combined Antiretroviral Treatment (cART) on Latent Cytomegalovirus Infection
by: Aura Temereanca, et al.
Published: (2025-01-01)

No preterm relative telomere length shortening in patients on successful cART
by: Gordana Dragovic, et al.
Published: (2024-12-01)

Asymptomatic HIV People Present Different Profiles of sCD14, sRAGE, DNA Damage, and Vitamins, according to the Use of cART and CD4+ T Cell Restoration
by: Karen Ingrid Tasca, et al.
Published: (2018-01-01)

Liberation from Dialysis Dependence in a Patient with HIV-Associated Nephropathy (HIVAN) after Combined Antiretroviral Therapy (cART)
by: Virin Ramoutar, et al.
Published: (2020-01-01)

Immunogenicity and Safety of BNT162b2 Homologous Booster Vaccination in People Living with HIV under Effective cART
by: Laura Gianserra, et al.
Published: (2022-08-01)

Impact of HIV-1 Subtype on the Time to CD4+ T-Cell Recovery in Combination Antiretroviral Therapy (cART)-Experienced Patients.
by: Wei Zhen Chow, et al.
Published: (2015-01-01)

Evaluation of the interventions on HIV case management and its association with cART adherence and disclosure of the disease status among HIV-positive adults under treatment
by: Awoke Seyoum Tegegne, et al.
Published: (2022-08-01)

Increased HIV-1 pretreatment drug resistance with consistent clade homogeneity among ART-naive HIV-1 infected individuals in Ethiopia
by: Mulugeta Kiros, et al.
Published: (2020-09-01)

Prevalence for the Disclosure of HIV Status to Sexual Partners and Its Determinants among Adults under cART in Amhara Region, Northwest Ethiopia
by: Awoke Seyoum Tegegne
Published: (2022-01-01)

A promising prognostic model for predicting survival of patients with HIV‐related diffuse large B‐cell lymphoma in the cART era
by: Juanjuan Chen, et al.
Published: (2023-06-01)

Subtype C HIV-1 reservoirs throughout the body in ART-suppressed individuals
by: Zhou Liu, et al.
Published: (2022-10-01)

Delay in cART initiation results in persistent immune dysregulation and poor recovery of T-cell phenotype despite a decade of successful HIV suppression.
by: Patricia Ndumbi, et al.
Published: (2014-01-01)

HIV maintains an evolving and dispersed population among multiple tissues during suppressive cART with periods of rapid expansion corresponding to the onset of cancer.
by: Rose, R, et al.
Published: (2016)

Differences in the direction of change of cerebral function parameters are evident over three years in HIV-infected individuals electively commencing initial cART.
by: Alan Winston, et al.
Published: (2015-01-01)

Self-reported adherence and pharmacy refill adherence are both predictive for an undetectable viral load among HIV-infected migrants receiving cART.
by: Sabrina K Been, et al.
Published: (2017-01-01)

Improved Central Nervous System Symptoms in People with HIV without Objective Neuropsychiatric Complaints Switching from Efavirenz to Rilpivirine Containing cART
by: Jaime H. Vera, et al.
Published: (2019-08-01)

PP 3.15 – 00207 A polyvalent HIV-1 virus-like particle formulation drives the majority of the infectious HIV-1 reservoir out of latency within CD4+ T cells of individuals receiving cART during chronic infection
by: E. Arts, et al.
Published: (2022-12-01)

Factors Associated with the Size of HIV DNA Reservoir
by: Ni-Dan Wang, et al.
Published: (2017-01-01)